Works matching IS 15228517 AND DT 2021 AND VI 23 AND IP 1
Results: 24
Reviewer Lists for the Year 2020.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 11, doi. 10.1093/neuonc/noaa304
- Publication type:
- Article
Breaking down the blood–brain barrier.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 6, doi. 10.1093/neuonc/noaa274
- By:
- Publication type:
- Article
Demystifying demethylator sensitivity in gliomas: role for TERT and DNMT1.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 7, doi. 10.1093/neuonc/noaa272
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 14, doi. 10.1093/neuonc/noaa271
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 172, doi. 10.1093/neuonc/noaa270
- Publication type:
- Article
In pursuit of glioma diagnosis: the challenges and opportunities of deep neural network augmented analyses.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 9, doi. 10.1093/neuonc/noaa262
- By:
- Publication type:
- Article
What is the burden of proof for tumor mutational burden in gliomas?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 17, doi. 10.1093/neuonc/noaa256
- By:
- Publication type:
- Article
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 34, doi. 10.1093/neuonc/noaa251
- By:
- Publication type:
- Article
The efficacy of anlotinib instead of glucocorticoids for edema induced by brain metastases in NSCLC patients with anti-PD1/PDL-1 immunotherapy.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 169, doi. 10.1093/neuonc/noaa236
- By:
- Publication type:
- Article
From anti-aging drugs to cancer therapy: is there a potential for sirtuin activators in gliomas?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 3, doi. 10.1093/neuonc/noaa234
- By:
- Publication type:
- Article
AI Neuropathologist: an innovative technology enabling a faultless pathological diagnosis?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 1, doi. 10.1093/neuonc/noaa229
- By:
- Publication type:
- Article
Management of gliomas in patients with Lynch syndrome.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 167, doi. 10.1093/neuonc/noaa227
- By:
- Publication type:
- Article
Rapid, label-free detection of diffuse glioma recurrence using intraoperative stimulated Raman histology and deep neural networks.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 144, doi. 10.1093/neuonc/noaa162
- By:
- Publication type:
- Article
NEO100 enables brain delivery of blood‒brain barrier impermeable therapeutics.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 63, doi. 10.1093/neuonc/noaa206
- By:
- Publication type:
- Article
Immune effector cell–associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 112, doi. 10.1093/neuonc/noaa183
- By:
- Publication type:
- Article
Sirtuin activation targets IDH-mutant tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 53, doi. 10.1093/neuonc/noaa180
- By:
- Publication type:
- Article
Artificial intelligence neuropathologist for glioma classification using deep learning on hematoxylin and eosin stained slide images and molecular markers.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 44, doi. 10.1093/neuonc/noaa163
- By:
- Publication type:
- Article
TERT and DNMT1 expression predict sensitivity to decitabine in gliomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 76, doi. 10.1093/neuonc/noaa207
- By:
- Publication type:
- Article
Synaptic input to brain tumors: clinical implications.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 23, doi. 10.1093/neuonc/noaa158
- By:
- Publication type:
- Article
NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 100, doi. 10.1093/neuonc/noaa153
- By:
- Publication type:
- Article
Clinical trial of proton craniospinal irradiation for leptomeningeal metastases.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 134, doi. 10.1093/neuonc/noaa152
- By:
- Publication type:
- Article
Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 88, doi. 10.1093/neuonc/noaa151
- By:
- Publication type:
- Article
Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 122, doi. 10.1093/neuonc/noaa145
- By:
- Publication type:
- Article
Clinical outcomes in a large pediatric cohort of patients with ependymoma treated with proton radiotherapy.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 156, doi. 10.1093/neuonc/noaa139
- By:
- Publication type:
- Article